Several markers capable of predicting ICI response have been previously studied extensively including PD-L1 expression, tumor mutational burden, the presence of neo-antigens in tumor microenvironment (TME) and the expression of IFN-γ signature [11, 12]. This evidence concerns the gene CD274 and neoplasm.